Alzheimer's Vaccines Are Back; Streamlining Prior Authorization; Rare APOE Variant

(MedPage Today) -- Interest in vaccines to treat Alzheimer's disease is back, according to interviews with 10 scientists and company executives. (Reuters) Personalized extended interval dosing using natalizumab (Tysabri) trough levels appeared...
Source: MedPage Today Neurology - Category: Neurology Source Type: news